Krystal Biotech Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$119,222	$116,357	$107,105	$97,800
Gross Profit	112,785	110,034	96,188	92,137
EBITDA	66,079	63,168	39,609	49,576
EBIT		61,442	37,844	47,967
Net Income	54,768	55,932	51,400	79,365
Net Change In Cash	119,222	116,357	107,105	97,800
Free Cash Flow	71,224	73,234	75,369	37,955
Cash	427,740	501,313	496,304	392,604
Basic Shares	30,657	30,507	29,951	29,833

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$389,130	$290,515	$50,699	$0
Gross Profit	360,357	270,454	47,605	-4,055
EBITDA	196,022	109,909	-91,316	-116,811
EBIT	189,471	103,195	-97,227	-120,196
Net Income	204,831	89,159	10,932	-139,975
Net Change In Cash	389,130	290,515	50,699	0
Free Cash Flow	188,914	119,182	-100,603	-153,548
Cash	496,304	344,865	358,328	161,900
Basic Shares	29,951	29,740	27,752	25,492